Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NASDAQ: NTRA), sold 4,639 shares of common stock on February 2nd and 3rd, 2026, under a Rule 10b5-1 trading plan, generating $1,072,537 in proceeds. The transactions occurred while Natera shares have shown notable six-month gains but recent short-term weakness. The company conti…
On February 2, 2026, CoreWeave CROWV Chief Development Officer Brannin McBee, via family trusts, sold 34,831 shares of Class A common stock for roughly $3.19 million under a Rule 10b5-1 plan adopted November 17, 2025. The company’s shares have since fallen to $82.46, down 17.15% over the prior week, even as a large NVIDIA equity investment and seve…
Natera Inc. President and Chief Business Officer John Fesko sold 3,594 shares of Natera stock on February 3, 2026, in two transactions totaling $830,278. The sales, executed under a Rule 10b5-1 trading plan to satisfy tax liabilities tied to vested restricted stock units granted in 2025 and 2026, leave Fesko with 178,081 shares. The transactions co…
Daniel Rabinowitz, Natera's Secretary and Chief Legal Officer, sold 1,334 shares on February 3, 2026, to meet tax obligations tied to RSU vesting. The transaction left him with 223,813 shares. Separately, Natera reported preliminary fourth-quarter results showing near 40% revenue growth and about 17% higher test volume, and advanced regulatory and …
Bank of America sold a small parcel of ENvue Medical stock on February 2, 2026, trimming part of its indirect position while remaining a large shareholder. The move was disclosed in an SEC Form 4. ENvue, recently rebranded from NanoVibronix and trading as FEED on Nasdaq, has announced commercial hires, a national distribution agreement for its ENFi…
Oil prices slid in Asian trading as traders trimmed a geopolitical risk premium after confirmation that U.S. and Iranian officials will meet in Oman on Friday. A firmer dollar, ahead of U.S. nonfarm payrolls and European and U.K. central bank decisions, compounded downward pressure even as U.S. inventory data provided some support.
Savannah Guthrie posted a video message asking anyone who may be holding her 84-year-old mother, Nancy Guthrie, to reach out and confirm she is alive after the elder woman went missing from her Arizona home. Authorities are treating the disappearance as a kidnapping and have noted the woman's limited mobility and need for daily medication.
South Korea's chief trade representative said Washington has not yet taken the administrative step required to raise tariff rates on South Korean goods and expressed confidence that such action is unnecessary while Seoul moves to implement the investment commitments in their bilateral trade agreement. Lawmakers in Seoul have agreed to target March …
Asian equity benchmarks declined as renewed concern about rising AI-related capital expenditure and a recent legal development involving a large language model pressured technology shares. Wall Street futures attempted a rebound after mixed corporate updates, while currencies, Treasuries and commodities reflected investor caution ahead of key earni…
Summary: Forgent Power Solutions Inc. has set the price for its initial public offering at $27.00 per share. The offering comprises shares sold by stockholders controlled by Neos Partners, LP and primary shares from Forgent, with underwriters granted a 30-day option to buy additional shares. Forgent will not receive proceeds from the shares sold by…
Achieve Life Sciences (ACHV) is a late-stage biotech focused on cytisinicline for smoking and vaping cessation. With an FDA review expected in June 2026, a successful approval could re-rate the company well above its current $225M market cap. This trade idea outlines an actionable long with entry, stop, targets, catalysts, and a clear risk framewor…
President Lai Ching-te said Taiwan's relationship with the United States remains 'rock-solid' and that existing cooperation programs and U.S. commitments will not change, following a phone call between Chinese President Xi Jinping and U.S. President Donald Trump in which Xi urged caution over arms sales to Taiwan.
President Donald Trump said he would prefer not to take sides between Vice President JD Vance and Secretary of State Marco Rubio as potential successors in the 2028 Republican presidential contest, praising both men and delaying any endorsement. He also reiterated an earlier, controversial suggestion that he might be president when the next term be…
East West Bancorp INC Chief Executive Officer Ng Dominic sold 50,000 shares on February 4, 2026, totaling $5.89 million. The trades were executed in two blocks at prices between $117.62 and $118.07 while EWBC traded close to a 52-week high. The move follows quarterly results that beat expectations and came amid analyst price-target adjustments.
Renesas Electronics reported an annual loss driven by higher finance costs and valuation writedowns on Wolfspeed-linked assets, even as margins held up and infrastructure-related sales rose. The company disclosed a deal to sell its timing business to SiTime for roughly $3 billion, sending shares sharply higher. Management forecast a sequential reve…
President Donald Trump has publicly backed Clay Fuller, a 44-year-old district attorney who prosecutes cases across four counties in northwest Georgia, in the upcoming special election to fill the U.S. House seat vacated by Marjorie Taylor Greene. The endorsement, posted on Truth Social, praises Fuller as an "America First Patriot" and a supporter …
Barbara Weber, identified as a director and Executive Chair of Tango Therapeutics (NASDAQ: TNGX), disposed of 30,519 shares on February 3, 2026 in two transactions totaling roughly $374,293. The move follows an equity award the prior day and occurs amid corporate developments including a $100 million at-the-market offering, a Stifel Buy rating with…
The U.S. dollar was steady in early Asian trading as investors awaited interest rate announcements from the European Central Bank and the Bank of England, both widely expected to keep policy rates unchanged. Market attention is on the ECB’s subsequent press conference for guidance on the near-term path of rates, while U.S. corporate earnings and he…
Eikon Therapeutics priced an upsized initial public offering of 21,177,600 common shares at $18.00 per share, with underwriters granted a 30-day option to buy an additional 3,176,640 shares at the same price. The company said the offering is expected to generate about $381 million in gross proceeds before deducting underwriting discounts, commissio…
FiscalNote Holdings director Tim Hwang sold 4,090 Class A common shares on February 2, 2026, in two transactions under a Rule 10b5-1 plan, realizing roughly $4,900 to satisfy tax obligations tied to vested restricted stock units. The transaction occurred while the company’s shares trade near a 52-week low and the firm reports solid gross margins an…
U.S. stock futures were modestly higher in evening trade after a session in which major indexes fell as technology and AI-related shares led declines. S&P 500 and Nasdaq Composite closed lower while the Dow rose. Market attention centered on Alphabet’s post-close results and weaker-than-expected private payrolls data, with traders awaiting weekly j…
Arcutis Biotherapeutics CFO Latha Vairavan sold 1,320 shares on Feb. 2, 2026 to satisfy tax withholding tied to restricted stock units. The transaction, totaling $33,657, comes as the company reports positive Phase 2 results for ZORYVE in infants, changes to its promotion arrangement, a board appointment, and an FDA acceptance for a pediatric psori…
Arcutis Biotherapeutics director Howard G. Welgus sold 10,000 shares on February 2, 2026, in transactions that generated roughly $250,483. The sales were executed through a 10b5-1 trading plan established in March 2025. The company meanwhile reported positive Phase 2 data for ZORYVE in infants, transitioned promotion responsibilities in-house, appo…
Alphatec Holdings Executive Vice President of People & Culture Craig E. Hunsaker sold 37,358 shares on February 3, 2026 under a pre-arranged Rule 10b5-1 trading plan to cover tax obligations tied to vested restricted stock units. The company posted preliminary fourth-quarter and full-year 2025 results that modestly beat expectations, but the stock …
According to a Yomiuri report, Taiwan Semiconductor Manufacturing Co. (TSMC) intends to mass produce advanced 3-nanometre chips at a new facility in Kumamoto, southern Japan, backed by an investment of $17 billion. Japan's government, which has already provided subsidies to expand TSMC capacity in Kyushu, is evaluating additional support for the pr…
